Literature DB >> 6816386

Induction in gonococci of phenotypic resistance to killing by human serum by human genital secretions.

P M Martin, P V Patel, N J Parsons, H Smith.   

Abstract

Cervical secretions and seminal plasmas from uninfected clinically healthy persons and vaginal exudates from patients with infections other than gonorrhoea converted gonococci susceptible to killing by fresh human serum to resistance after three hours' incubation at 37 degrees C. The inducing factors present in the genital secretions explain the serum resistance of gonococci from patients with acute urethritis. This serum resistance is lost on subculture in laboratory media but could play an important role in vivo in the survival of gonococci in the initial stages of urogenital infection when serum factors are liberated into the local infection site during inflammation.

Entities:  

Mesh:

Year:  1982        PMID: 6816386      PMCID: PMC1046102          DOI: 10.1136/sti.58.6.363

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


  6 in total

1.  Induction of phenotypically determined resistance of Neisseria gonorrhoeae to human serum by factors in human serum.

Authors:  P M Martin; P V Patel; N J Parsons; H Smith
Journal:  J Gen Microbiol       Date:  1981-11

2.  Maintenance of virulent gonococci in laboratory culture.

Authors:  P J Watt; A A Glynn; M E Ward
Journal:  Nat New Biol       Date:  1972-04-12

3.  Gonococci in urethral exudates possess a virulence factor lost on subculture.

Authors:  M E Ward; P J Watt; A A Glynn
Journal:  Nature       Date:  1970-07-25       Impact factor: 49.962

4.  Selection from gonococci grown in vitro of a colony type with some virulence properties of organisms adapted in vivo.

Authors:  C W Penn; D R Veale; H Smith
Journal:  J Gen Microbiol       Date:  1977-05

5.  Factors affecting the induction of phenotypically determined serum resistance of Neisseria gonorrhoeae grown in media containing serum or its diffusible components.

Authors:  D R Veale; C W Penn; H Smith
Journal:  J Gen Microbiol       Date:  1981-02

6.  Phenotypic changes in the resistance of Neisseria gonorrhoeae to killing by normal human serum.

Authors:  S C Rittenberg; C W Penn; N J Parsons; D R Veale; H Smith
Journal:  J Gen Microbiol       Date:  1977-11
  6 in total
  8 in total

1.  Gonococci in vivo: Host CMP-NANA, sialylated lipopolysaccharide and serum resistance.

Authors:  H Smith
Journal:  Can J Infect Dis       Date:  1993-01

2.  Alpha-2,3-sialyltransferase enhances Neisseria gonorrhoeae survival during experimental murine genital tract infection.

Authors:  Hong Wu; Ann E Jerse
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 3.  Molecular basis for serum resistance in Neisseria gonorrhoeae.

Authors:  P A Rice
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

4.  Anaerobic growth and cytidine 5'-monophospho-N-acetylneuraminic acid act synergistically to induce high-level serum resistance in Neisseria gonorrhoeae.

Authors:  J V Frangipane; R F Rest
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

5.  Gonococcal lipooligosaccharide sialylation: virulence factor and target for novel immunotherapeutics.

Authors:  Sanjay Ram; Jutamas Shaughnessy; Rosane B de Oliveira; Lisa A Lewis; Sunita Gulati; Peter A Rice
Journal:  Pathog Dis       Date:  2017-06-01       Impact factor: 3.166

6.  Induction by human serum of resistance to serum in Neisseria gonorrhoeae: A clinical survey of patients with gonorrhoea.

Authors:  P M Martin; P V Patel; J C Clay; N J Parsons; H Smith
Journal:  Br J Vener Dis       Date:  1984-06

7.  Growth of Neisseria gonorrhoeae in CMP-N-acetylneuraminic acid inhibits nonopsonic (opacity-associated outer membrane protein-mediated) interactions with human neutrophils.

Authors:  R F Rest; J V Frangipane
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

8.  Heparin protects Opa+ Neisseria gonorrhoeae from the bactericidal action of normal human serum.

Authors:  T Chen; J Swanson; J Wilson; R J Belland
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.